ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Poxel

Poxel (POXEL)

0.565
0.011
(1.99%)
Closed September 21 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.565
Bid
0.56
Ask
0.565
Volume
168,369
0.555 Day's Range 0.574
0.297 52 Week Range 0.95
Market Cap
Previous Close
0.554
Open
0.56
Last Trade
39
@
0.565
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
305,047
Shares Outstanding
46,586,753
Dividend Yield
-
PE Ratio
-0.83
Earnings Per Share (EPS)
-0.67
Revenue
674k
Net Profit
-31.4M

About Poxel

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Lyon, Rhone, Fra
Founded
-
Poxel is listed in the Pharmaceutical Preparations sector of the Euronext with ticker POXEL. The last closing price for Poxel was 0.55 €. Over the last year, Poxel shares have traded in a share price range of 0.297 € to 0.95 €.

Poxel currently has 46,586,753 shares outstanding. The market capitalization of Poxel is 25.81 € million. Poxel has a price to earnings ratio (PE ratio) of -0.83.

POXEL Latest News

Poxel publie son chiffre d'affaires pour le deuxième trimestre et le premier semestre 2024 et dresse un bilan de ses activités

Ventes de TWYMEEG® au Japon pour le deuxième trimestre (avril-juin) en hausse de 62% par rapport au trimestre précédent (janvier-mars) Finalisation en cours des discussions exclusives avec un...

Poxel : nombre d’actions et de droits de vote composant le capital social

Regulatory News: Poxel (Paris:POXEL) : Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers...

Poxel : nombre d’actions et de droits de vote composant le capital social

Regulatory News: Poxel (Paris:POXEL): conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers («...

Sumitomo Pharma and Poxel Announce Topline Results from Post-Marketing Clinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan

Safety and tolerability profile observed, consistent with prior clinical studies in the general type 2 diabetes population Based on the results, Sumitomo Pharma is planning to conduct...

Poxel fait le point sur sa situation financière pour les deuxième trimestre et premier semestre 2024 et annonce le report de son Assemblée Générale Annuelle

Extension approuvée au Japon de 2 brevets de TWYMEEG® jusqu’en 2036 Finalisation en cours des discussions exclusives avec un investisseur de premier plan afin de monétiser les redevances issues...

Poxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update

TWYMEEG® gross sales in Japan for Sumitomo Pharma Fiscal Year 20231 reached JPY 4.6 billion (EUR 27.9 million)2, exceeding guidance3 by more than 8% TWYMEEG®’s FY 2024 forecast4 of JPY 11.3...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0152.727272727270.550.5740.5211307640.53715698DE
4-0.023-3.911564625850.5880.6090.5211672410.56680308DE
120.0183.290676416820.5470.7470.4383050470.58644659DE
260.0234.243542435420.5420.8980.4383133080.6197151DE
520.06613.22645290580.4990.950.2972461540.57565985DE
156-5.845-91.18564742596.416.4150.2971372641.02419968DE
260-6.935-92.46666666677.513.80.2971385733.66492792DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLSMLSmalto
0.018 €
(100.00%)
130.1k
MLPRXParx Materials NV
0.10 €
(66.67%)
36k
ALQGCQuantum Genomics
0.0295 €
(35.94%)
17.64M
CROSCrosswood
8.70 €
(16.00%)
14
ALMDTMedian Technologies
4.505 €
(12.63%)
513.52k
NAIWNew Amsterdam Invest NV
0.05 €
(-44.44%)
721
ALTROTronic s Microsystems
3.70 €
(-32.11%)
304
LIGLisgrafica
0.004 €
(-27.27%)
13.87k
MLUMGUmalis Group
1.37 €
(-19.41%)
33
ALAGOEPango SA
0.223 €
(-18.32%)
1.1M
BCPBanco Comercial Portugues SA
0.4189 €
(0.84%)
74.08M
ALNEVNeovacs
0.0006 €
(0.00%)
59.09M
ALTDTonner Drones
0.0082 €
(-14.58%)
24.89M
AGNAegon Ltd
5.61 €
(-0.43%)
23.84M
KPNKoninklijke KPN NV
3.626 €
(0.53%)
21.47M

Discussion

View Full Feed
cjstocksup cjstocksup 5 seconds ago
https://x.com/DC_Draino/status/1836864647984541983
Tree Tree 31 seconds ago
Hope thar smaller wager is really small or better yet, you didn't see my last message
SkyLimit2022 SkyLimit2022 35 seconds ago
ex,

I have no idea what everyone else on Earth ever said. I was answering LC’s accusation that “disciples” lied on the board today.

It seems like some posters are desperate and hostile lately … posting anything to keep the argument going ..anything to distract from th
NWBO
BADALI BADALI 44 seconds ago
Stop spreading fake information. You already did one before.
IGPK
cjstocksup cjstocksup 1 minute ago
https://x.com/DC_Draino/status/1836867323468337213
NorthTrail NorthTrail 2 minutes ago
In my DD I saw that .25 which I liked but thought I saw some a further provision for lesser amount. Convoluted document. Hopefully I'm wrong.
TXTM
Aero-man Aero-man 2 minutes ago
Sadly, board shit-heads, docsetc, jerk-n-hard & squidster, have had their collective bung-holes reamed out in one of their past ventures that went south - get over it already. Move on whack-jobs, you accomplish ZERO here.
HALB
LVerstee LVerstee 2 minutes ago
Sure. Keep telling yourself that.
Don't try and sell that BS to others.
ITUP
janice shell janice shell 2 minutes ago
Yes indeed. Chicken is relatively inexpensive and easily portioned. It goes with all kinds of sauces, and can be accompanies by all kinds of veggies and other sides. What's not to like?

The recipe is Kenji's, so of course he had to start with a chimney full of charcoal. But I'm sure i
cjstocksup cjstocksup 3 minutes ago
https://x.com/DC_Draino/status/1836873039121936741
RealDutch RealDutch 5 minutes ago
It's the reality, Verstee. I have close to $1.3M in cash coming next month. And substantial monthly dividends starting in November. And not much to spend my money on. There is only one other stock I want to buy.

We are going to have BIG FUN. Really looking forward to it.
ITUP
RealDutch RealDutch 5 minutes ago
It's the reality, Verstee. I have close to $1.3M in cash coming next month. And substantial monthly dividends starting in November. And not much to spend my money on. There is only one other stock I want to buy.

We are going to have BIG FUN. Really looking forward to it.
ITUP
Itchy palm Itchy palm 6 minutes ago
Definitely Timberdumb .😁
GetSeriousOK GetSeriousOK 7 minutes ago
you think people are viewing this stock MB to find solutions for pain?

You can't believe that.

You're just mindlessly PUMPING. Doesn't matter whether you admit it or not.
BIEL
DR_rugby DR_rugby 7 minutes ago
Who’s got the Kitty’s Back??

https://m.youtube.com/watch?v=weQd__HCfnQ

Cuz I got the belly

GLTA
GME
cjstocksup cjstocksup 7 minutes ago
https://x.com/DC_Draino/status/1836878523430228112
cjstocksup cjstocksup 8 minutes ago
https://x.com/DC_Draino/status/1836921025184838128
janice shell janice shell 8 minutes ago
Depositions are conduction in just about every civil case brought. By the SEC or another plaintiff.
cjstocksup cjstocksup 9 minutes ago
https://x.com/DC_Draino/status/1837124250760626305
flipper44 flipper44 9 minutes ago
How could you possibly know there will be no MHRA news?

You can’t.

It’s that simple. You are giving an opinion.

Note: I don’t take issue with your first two full paragraphs, although LG chose to simply fudge, I think there were likely good internal re
NWBO
cjstocksup cjstocksup 10 minutes ago
https://x.com/DC_Draino/status/1837124942611009659
cjstocksup cjstocksup 11 minutes ago
https://x.com/DC_Draino/status/1837166012518568195
bb8675309 bb8675309 11 minutes ago
Right on, georgejjl. Heck ya. Sign me up for that Amazon home delivery. People have seen enough in over 8 years of Blarcamesine drug trial results. It's proven safety record is phenomenal. We want access to Blarcamesine now. imo
AVXL
richme richme 12 minutes ago
At 0004-0006, they are all cheapies. Hope these are good bait for a great return.
ASII

Your Recent History

Delayed Upgrade Clock